1. Imbalance between MMP-2, 9 and TIMP-1 promote the invasion and metastasis of renal cell carcinoma via SKP2 signaling pathways
    Hongsheng Lu et al, 2014, Tumor Biology CrossRef
  2. Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT
    Peter J Selby et al, 2018, Programme Grants for Applied Research CrossRef
  3. Review—Measurement and Analysis of Cancer Biomarkers Based on Electrochemical Biosensors
    Feiyun Cui et al, 2020, Journal of The Electrochemical Society CrossRef
  4. Matrix Metalloproteinases in Renal Diseases: A Critical Appraisal
    Oskar Zakiyanov et al, 2019, Kidney and Blood Pressure Research CrossRef
  5. Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?
    Magdalena Chrabańska et al, 2023, Cancers CrossRef
  6. MMPs-related risk model identification and SAA1 promotes clear cell renal cell carcinoma migration via ERK-AP1-MMPs axis
    Haotian Wei et al, 2024, Scientific Reports CrossRef
  7. Cancer-Specific Survival Stratification Derived from Tumor Expression of Tissue Inhibitor of Metalloproteinase-2 in Non-Metastatic Renal Cell Carcinoma
    Pastora Beardo et al, 2019, Pathology & Oncology Research CrossRef
  8. Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay method
    Christian Niedworok et al, 2016, International Urology and Nephrology CrossRef
  9. Matrix Metalloproteinases in Kidney Disease: Role in Pathogenesis and Potential as a Therapeutic Target
    Alan R. Parrish, 2017, Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Target Tissues and Therapy CrossRef
  10. Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells
    Jingyuan Song et al, 2016, Tumor Biology CrossRef
  11. Asiatic acid from centella asiatica exert anti-invasive ability in human renal cancer cells by modulation of ERK/p38MAPK-mediated MMP15 expression
    Chien-Feng Huang et al, 2022, Phytomedicine CrossRef
  12. The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression
    Ruth Escalona et al, 2018, International Journal of Molecular Sciences CrossRef
  13. Diagnostic value of pseudocapsule ring hyperenhancement in contrast-enhanced ultrasound in renal focal lesions
    Ligang Wang et al, 2023, Irish Journal of Medical Science (1971 -) CrossRef
  14. MMPs, tyrosine kinase signaling and extracellular matrix proteolysis in kidney cancer
    Fiza Hashmi et al, 2021, Urologic Oncology: Seminars and Original Investigations CrossRef
  15. Amperometric Biosensor of Matrix Metalloproteinase-7 Enhanced by Pd-Functionalized Carbon Nanocomposites
    Zheng Wei et al, 2018, Nanoscale Research Letters CrossRef
  16. Expression of basement membrane genes and their prognostic significance in clear cell renal cell carcinoma patients
    Junyue Tao et al, 2022, Frontiers in Oncology CrossRef
  17. The Many Faces of Matrix Metalloproteinase-7 in Kidney Diseases
    Zhao Liu et al, 2020, Biomolecules CrossRef
  18. The anti-inflammatory protein MCPIP1 inhibits the development of ccRCC by maintaining high levels of tumour suppressors
    Judyta Gorka et al, 2020, European Journal of Pharmacology CrossRef
  19. Biomarkers for the Detection and Surveillance of Renal Cancer
    José Ignacio Nolazco et al, 2023, Urologic Clinics of North America CrossRef
  20. Normalization of the tumor microenvironment: evidence for tissue inhibitor of metalloproteinase-2 as a cancer therapeutic
    William G. Stetler-Stevenson et al, 2014, Connective Tissue Research CrossRef
  21. Biomarkers of Renal Cancer
    N.S. Vasudev et al, 2017, Biomarkers of Kidney Disease CrossRef